Antiva Biosciences

Redwood City, CA · Founded 2012 · Privately Held (backing)

Developer of small molecule antivirals designed to improve health outcomes for patients suffering from diseases caused by HPV and other viruses. Antiva Biosciences is based in Redwood City, CA and was founded in 2012. Its last known valuation is $123 million. It has raised $145 million across 4 recorded rounds; the latest was a $38.5 million early-stage round in Apr 2023.

Last price · $/share
—
Implied valuation
$123.0M
Total raised
$144.8M
Last round
Early Stage VC
Apr 2023

Who backs Antiva Biosciences?

21 investors
InvestorType
Mana VenturesVenture capital
GaingelsVenture capital
GVVenture capital
University of CaliforniaOther
Alexandria Venture InvestmentsOther
Canaan PartnersVenture capital
Johnson & Johnson Innovation - JLABSOther
Hillhouse Investment GroupOther
Osage University PartnersVenture capital
HBM PartnersVenture capital
+ 11 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Antiva Biosciences investors

21 investors are on record for Antiva Biosciences, including Mana Ventures, Gaingels, GV and University of California. By type, the record holds 7 venture capital firms. The early-stage round in Apr 2023 drew 21 investors.

Free account
More of Antiva Biosciences with a free account
  • ·The complete investor list: 21 names
  • ·Watch Antiva Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 21 firms already write checks for companies like Antiva Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View